ETF Worth Watching: Direxion Daily S&P Biotech Bull 3X ETF (LABU) Declines 8.34% for Nov 22

November 22, 2016 - By Hazel Jackson   ·   0 Comments

Nov 22 is a negative day so far for Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABU) as the ETF is active during the day after losing 8.34% to hit $41.66 per share. The exchange traded fund has 235.42M net assets and 9.18% volatility this month.

Over the course of the day 438,689 shares traded hands, as compared to an average volume of 3.19M over the last 30 days for Direxion Daily S&P Biotech Bull 3X ETF (NYSEARCA:LABU).

The ETF is -55.04% of its 52-Week High and 138.79% of its low, and is currently having ATR of 3.8. This year’s performance is -46.24% while this quarter’s performance is 2.72%.

The ETF’s YTD performance is -65.7%, the 1 year is -62.4% and the 3 year is NaN%.

The ETF’s average P/E ratio is 21.11, the price to book is 3.23, the price to sales is 8.39 and the price to cashflow is 11.96. It was started on 5/28/2015. The fund’s top holdings are: S&P Biotechnology Select Industry USD for 90.25% of assets, S&P Biotechnology Select for 58.05%, Goldman Finl Sq Trsry Ins for 9.45%, SPDR® S&P Biotech ETF for 3.60%, Fidelity Institutional Go for 0.00%. The ETF sector weights are: Healthcare 100.00%. The ETF currently as yield.

More notable recent Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) news were published by: Marketwatch.com which released: “Direxion Daily S&P Biotech Bull 3X Shares” on March 08, 2014, also Quotes.Wsj.com with their article: “DOW JONES, A NEWS CORP COMPANY” published on May 29, 2015, Etftrends.com published: “Triple-Leveraged Biotech ETFs Could be Coming Soon” on March 20, 2015. More interesting news about Direxion Daily S&P Biotech Bull 3X Shares (NYSEARCA:LABU) were released by: Investorplace.com and their article: “Be Careful Before Loving Leveraged Biotech ETFs” published on October 06, 2015 as well as Etftrends.com‘s news article titled: “Direxion to Reverse Split 8 ETFs, Forward Split Two Others” with publication date: February 24, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Hazel Jackson


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>